INFINITY PHARMACEUTICALS INC's ticker is INFI and the CUSIP is 45665G303. A total of 101 filers reported holding INFINITY PHARMACEUTICALS INC in Q1 2014. The put-call ratio across all filers is 1.89 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2015 | $0 | -100.0% | 3 | -62.5% | 0.00% | – |
Q3 2015 | $3,000 | +50.0% | 8 | -38.5% | 0.00% | – |
Q2 2015 | $2,000 | -66.7% | 13 | -40.9% | 0.00% | – |
Q1 2015 | $6,000 | -83.8% | 22 | -85.3% | 0.00% | -100.0% |
Q4 2014 | $37,000 | -47.9% | 150 | -35.1% | 0.00% | -50.0% |
Q3 2014 | $71,000 | +54.3% | 231 | +23.5% | 0.00% | +100.0% |
Q2 2014 | $46,000 | +12.2% | 187 | +26.4% | 0.00% | 0.0% |
Q1 2014 | $41,000 | -90.2% | 148 | -99.4% | 0.00% | -87.5% |
Q4 2013 | $419,000 | – | 23,930 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
BVF INC/IL | 7,866,108 | $25,408,000 | 4.32% |
Nine Chapters Capital Management LLC | 91,500 | $296,000 | 0.40% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,969,225 | $6,361,000 | 0.24% |
Orbimed Advisors | 3,250,300 | $10,498,000 | 0.12% |
PINNACLE ASSOCIATES LTD | 1,306,679 | $4,221,000 | 0.08% |
PLATINUM INVESTMENT MANAGEMENT LTD | 810,232 | $2,617,000 | 0.07% |
BOGLE INVESTMENT MANAGEMENT L P /DE/ | 270,417 | $873,000 | 0.06% |
Rock Springs Capital Management LP | 270,000 | $872,000 | 0.05% |
ALGERT GLOBAL LLC | 39,876 | $129,000 | 0.04% |
JACOBS LEVY EQUITY MANAGEMENT, INC | 391,671 | $1,265,000 | 0.03% |